Since BII’s inauguration in 2018, we have supported 130 startups and translational projects that have raised EUR 626M, thereby leveraging the financial support provided by BII sixfold. Furthermore, the supported companies have created more than 600 new workplaces and are well in the process of bringing their products, technologies, and solutions to market to benefit human and planetary health.  

To build on this success and fulfill future ambitions, we are announcing reorganizational changes in our management team today. Trine Bartholdy will step into the role of Chief Business Officer (CBO) with a clear focus on ensuring BII provides the best offerings and framework for our start-ups and translational research projects to go to market. She will also work diligently with her team to strengthen ties to the academic environment and explore valuable partnerships with the industrial sector to create an even better foundation for bringing ideas to life and research to market.  

Bobby Soni will step into a new role as Chief International Officer (CIO), and in close collaboration with the rest of BII’s management team, he will work on a number of strategic initiatives to advance BII and ensure that we can create an even greater impact in the future. 

“BII is an organization in constant development. Since 2018, we have experienced growth in the number of startups and initiatives we support. I believe these reorganizational changes help to create the best framework and prerequisites for BII to develop further and to fulfill its mission of supporting talented researchers and entrepreneurs to commercialize their good ideas to benefit society,” says Jens Nielsen, CEO of BioInnovation Institute.